Status:

COMPLETED

XPAND Trial: Enhancing XP Photoprotection Activities - New Directions

Lead Sponsor:

Guy's and St Thomas' NHS Foundation Trust

Collaborating Sponsors:

King's College London

Newcastle University

Conditions:

Xeroderma Pigmentosum

Eligibility:

All Genders

16+ years

Phase:

NA

Brief Summary

People with Xeroderma Pigmentosum (XP) have a genetic condition which stops their skin repairing damage from Ultraviolet Radiation (UVR). This means they are much more likely to develop potentially fa...

Detailed Description

Xeroderma Pigmentosum (XP) is a rare autosomal recessive inherited condition caused by defective Nucleotide Excision Repair. Patients may develop skin cancers from childhood onwards, ocular damage, an...

Eligibility Criteria

Inclusion

  • A confirmed diagnosis (on the basis of DNA repair study results) of Xeroderma Pigmentosum
  • Age \>16 years
  • Sub-optimal adherence to photoprotection when outdoors, identified by clinical team from data held in medical notes.
  • For those who participated in our previous research study, sub-optimal adherence will be confirmed from data collected during that study. They will be eligible if they meet any of the following criteria:
  • Score \<20 on the Adherence to Photoprotection scale (total score is 25 - optimal protection) from a cross-sectional questionnaire completed during our previous research.
  • Using photoprotective clothing that have been assessed by the clinical team as anything other than "very good or excellent" on anytime outdoors, recorded on the daily UVR protection diary.
  • Having a "resistant" mode of adjustment to photoprotection in the qualitative analysis

Exclusion

  • Adults diagnosed with cognitive impairment
  • Adults with inadequate English to be able to converse with the intervention facilitators
  • Adults diagnosed with current clinical depression or anxiety

Key Trial Info

Start Date :

March 30 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2020

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT03445052

Start Date

March 30 2018

End Date

January 30 2020

Last Update

July 22 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Guy's St Thomas' NHS Foundation Trust

London, United Kingdom, SE1 7EH